reports
Oil-Dri to Acquire Ultra Pet in Strategic Move to Compete in Rapidly G...
Oil-Dri to Acquire Ultra Pet in Strategic Move to Compete in Rapidly Growing Crystal Cat Litter Market CHICAGO, April 16, 2024 (GLOBE NEWSWIRE) -- Oil-Dri Corporation of America (NYSE: ODC) (“Oil-Dri”), a leading manufacturer of sorbent minerals including clay-based cat litter, announced today that it has entered into a definitive agreement to acquire privately-held Ultra Pet Company, Inc. (“Ultra Pet”), a prominent supplier of silica gel-based crystal cat litter. Under the terms of the agreement, Oil-Dri will acquire Ultra Pet for $46 million in cash. Oil-Dri plans to finance this acqui...
SiriusPoint Announces Date for First Quarter 2024 Earnings Release
SiriusPoint Announces Date for First Quarter 2024 Earnings Release HAMILTON, Bermuda, April 16, 2024 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (NYSE: SPNT) (“SiriusPoint” or the “Company”) today announced that it is planning to release its first quarter 2024 financial results after the market close on Tuesday, April 30, 2024. The Company will also hold a webcast, which can be accessed as a conference call, to discuss its financial results at 8:30 am (Eastern Time) on Wednesday, May 1, 2024. The webcast of the live conference call can be accessed by logging onto the Investor Relations section ...
Ultimovacs Implements Operational Adjustments to Support Continuous Ad...
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program Due to the broad diversity in the UV1 Phase II program and the encouraging results from previous UV1 trials, Ultimovacs remain confident in UV1’s potential and are strongly committed to bringing the company across the next important data points: The readout from FOCUS in Q3 2024 and DOVACC results in H1 2025Activity level adjustments and operational prioritization are implemented to sustain the financial runway, including a workforce reduction of approximately 40% Th...
Angi Inc. to Announce Q1 2024 Earnings on May 7th and Host Earnings Co...
Angi Inc. to Announce Q1 2024 Earnings on May 7th and Host Earnings Conference Call on May 8th DENVER, April 16, 2024 (GLOBE NEWSWIRE) -- After the close of market trading on Tuesday, May 7, 2024, Angi Inc. (NASDAQ: ANGI) will post its first quarter results at . On Wednesday May 8, 2024, at 8:30 a.m. ET, Angi Inc. and IAC will host a conference call to answer questions regarding the companies’ respective first quarter results. The live audiocast and replay will be open to the public through the investor relations section of the Angi site at . About Angi Inc. Angi (NASDAQ: ANGI) helps...
Rumble Announces Timing of First Quarter 2024 Earnings Release and Con...
Rumble Announces Timing of First Quarter 2024 Earnings Release and Conference Call LONGBOAT KEY, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Rumble Inc. (NASDAQ: RUM) (“Rumble” or the “Company”), the video platform and cloud services provider, today announced that it will release financial results for the fiscal quarter ended March 31, 2024 after the close of markets on Tuesday, May 14, 2024. The Company will host a conference call on the same day at 5:00 p.m. Eastern Time. Access to the live webcast and replay of the conference call, along with related earnings release materials, will be a...
Intra-Cellular Therapies Announces Proposed Public Offering of Common ...
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it has commenced an underwritten public offering of $500 million of shares of its common stock. In connection with the offering, Intra-Cellular Therapies intends to grant the underwriters a 30-day option to purchase up to an additional 15% ...
New York Mortgage Trust 2024 First Quarter Conference Call Scheduled f...
New York Mortgage Trust 2024 First Quarter Conference Call Scheduled for Thursday, May 2, 2024 NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) is scheduled to report financial results for the three months ended March 31, 2024 after the close of market on May 1, 2024. New York Mortgage Trust's executive management will host a conference call and audio webcast at 9:00 a.m., Eastern Time, on Thursday, May 2, 2024. To access the conference call, please pre-register using this . Registrants will receive confirmation with dial-in details...
Vespra Hills Golf Club Joins the ClubLink Family of Managed Clubs
Vespra Hills Golf Club Joins the ClubLink Family of Managed Clubs KING CITY, Ontario, April 16, 2024 (GLOBE NEWSWIRE) -- ClubLink Corporation ULC (subsidiary of TWC Enterprises Limited), Canada’s largest owner, operator and manager of Golf and Country Clubs, announced today that Vespra Hills Golf Club has joined the ClubLink family of managed Clubs. Established in 2003, nestled in the hills of Springwater Township, 10 minutes from downtown Barrie, Ontario and 45 minutes from the highway 407/400 interchange, the 27-hole Member Club will become a fully integrated, Gold-level Member Club ...
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4...
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) DURHAM, N.C., April 16, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX) today announced that on April 10, 2024, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to four new employees of non-statutory stock options to purchase up to a total of 223,000 shares of Chimerix’s common stock. The Compensation Committee of Chimerix’s Board of Directors approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing rule 5635(c)(4). The stock...
Open Lending to Announce First Quarter 2024 Results on May 7, 2024
Open Lending to Announce First Quarter 2024 Results on May 7, 2024 AUSTIN, Texas, April 16, 2024 (GLOBE NEWSWIRE) -- Corporation (NASDAQ: LPRO) (“Open Lending” or “the Company”), an industry trailblazer in automotive lending enablement and risk analytics solutions for financial institutions, today announced that the Company will host a conference call to discuss first quarter 2024 financial results on Tuesday, May 7, 2024 at 5:00pm ET. A press release with first quarter 2024 financial results will be issued after the market closes that same day. The conference call will be webcast live ...
Flywire to Announce First Quarter 2024 Results on May 7, 2024
Flywire to Announce First Quarter 2024 Results on May 7, 2024 BOSTON, April 16, 2024 (GLOBE NEWSWIRE) -- Today, (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, announced that its first quarter 2024 financial results will be released after market close on Tuesday, May 7, 2024. Flywire will host a conference call to discuss its first quarter 2024 financial results at 5:00pm ET the same day. Hosting the call will be Mike Massaro, CEO, Rob Orgel, President and COO, Cosmin Pitigoi, CFO, and Akil Hollis, Head of Investor Relations. The conference call will be web...
SuRo Capital Corp. First Quarter 2024 Preliminary Investment Portfolio...
SuRo Capital Corp. First Quarter 2024 Preliminary Investment Portfolio Update Net Asset Value Anticipated to be $6.90 to $7.40 Per Share NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: ) today provided the following preliminary update on its investment portfolio for the first quarter ended March 31, 2024. “We remain incredibly enthusiastic about both our investment pipeline and our current portfolio as the IPO market strengthens and new opportunities at compelling valuations continue to come to light. We are now executing on...
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Hea...
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that William Ho, CEO and Co-founder, will present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference on Thursday, April 18th at 12:30pm ET. The formal presentation will feature a fireside style Q&A session with questions welcome from the live virtual audience. Attendees interested in viewing t...
Connect Biopharma Reports Full Year 2023 Financial Results and Provide...
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update Reported two positive readouts for rademikibart, the Company’s lead asset, from the Global Phase 2b trial in moderate-to-severe persistent asthma and from the China pivotal trial in moderate-to-severe atopic dermatitis (AD)Type C meeting in AD and End-of-Phase 2 (EoP2) meeting in asthma have been scheduled with the U.S. Food and Drug Administration (FDA) in Q2 2024 to discuss trial results and proposed registrational programsGranted Simcere the exclusive rights to develop, manufacture, and commercialize ...
Cricut to Announce First Quarter 2024 Financial Results on May 7, 2024
Cricut to Announce First Quarter 2024 Financial Results on May 7, 2024 SOUTH JORDAN, Utah, April 16, 2024 (GLOBE NEWSWIRE) -- Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced it will report its financial results for the first quarter ended March 31, 2024 after the U.S. markets close on Tuesday, May 7, 2024. Cricut management will host a conference call and webcast to discuss the results that afternoon at 3:00 p.m. Mountain Time (5:00 p.m. Eastern Time). A live webcast o...
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listin...
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on April 12, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4). In the aggregat...
A-Mark Precious Metals Sets Fiscal Third Quarter 2024 Earnings Call fo...
A-Mark Precious Metals Sets Fiscal Third Quarter 2024 Earnings Call for Tuesday, May 7, at 4:30 p.m. ET EL SEGUNDO, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, will hold a conference call on Tuesday, May 7, 2024 at 4:30 p.m. Eastern time to discuss results for the fiscal third quarter ended March 31, 2024. Financial results will be issued in a press release prior to the call. A-Mark management will host the presentation, followed by a question-and-answer period. A-Mark’s conference call can be accessed as follo...
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient ...
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations ASPIRE-FTD Sites in the EU and U.S. to Use ClearPoint® Navigation Together With SmartFlow® Cannula for Intrathalamic Gene Therapy Administration SOLANA BEACH, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner AviadoBio on treat...
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listin...
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) CONSHOHOCKEN, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that the company granted equity awards to 7 new employees, in each case with a grant date of April 15, 2024, as equity inducement awards under the terms of the company's 2023 Inducement Plan. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). The equity award...
ALLETE Recognized for Gender Diversity on Board and Among Executive Of...
DULUTH, Minn.--(BUSINESS WIRE)-- ALLETE, Inc. (NYSE:ALE) has been named an Honor Roll company of Special Distinction in an annual report on gender diversity in the executive ranks and on the boards of directors of the largest publicly traded companies in Minnesota. St. Catherine University conducts the research each year and the resulting report, called “,” is published by Twin Cities Business. For 2023, ALLETE was among nine companies to qualify for Special Distinction status and one of only three companies to have reached gender parity on both their boards and among their executive officer...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.